Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WA1R
|
|||
| Former ID |
DIB005983
|
|||
| Drug Name |
Keratinocyte growth factor
|
|||
| Synonyms |
RHu-KGF
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [1] | |
| Company |
Amgen
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Keratinocyte growth factor (FGF7) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant. J Clin Oncol. 2003 Apr 15;21(8):1452-8. | |||
| REF 2 | Keratinocyte growth factor.Cell Biol Int.1995 May;19(5):399-411. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.